N6-Methyladenosine (m6A)-Mediated Regulation of Lipid Metabolism: Molecular Mechanisms, Pathological Implications, and Therapeutic Perspectives
Biomolecules · 2026
DOI: 10.3390/biom16010101 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2026. Verfasst von Qingjun Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science and Technology, Southwest University, Chongqing 400715, China. Hauptthemen laut MEDLINE: Adenosine, Lipid Metabolism. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Chongqing Graduate Student Research Innovation Project, Science and technology research project of Chongqing Municipal Education Commission.
Abstract (Originalsprache)
Dysregulated lipid metabolism constitutes the fundamental etiology underlying the global burden of obesity and its associated metabolic disorders. N6-methyladenosine (m6A) is the most abundant reversible chemical modification on messenger RNA and influences virtually every aspect of RNA metabolism. Recent studies demonstrate that m6A mediates regulatory networks governing lipid metabolism and contributes to the pathogenesis of multiple metabolic diseases. However, the precise roles of m6A in lipid metabolism and related metabolic disorders remain incompletely understood. This review positions m6A modification as a central epigenetic switch that governs lipid homeostasis. We first summarize the molecular components of the dynamic m6A regulatory machinery and delineate the mechanisms by which it controls key lipid metabolic processes, with an emphasis on adipogenesis, thermogenesis and lipolysis. Building on this, we further discuss how dysregulated m6A acts as a shared upstream driver linking obesity, type 2 diabetes (T2D), metabolic dysfunction-associated steatotic liver disease (MASLD), and insulin resistance through tissue-specific and inter-organ communication mechanisms. We also evaluate the potential of targeting m6A regulators as therapeutic strategies for precision intervention in metabolic diseases. Ultimately, deciphering the complex interplay between m6A modification and lipid homeostasis offers a promising frontier for the development of epitranscriptome-targeted precision medicine against obesity and its associated metabolic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Animal Science and Technology, Southwest University, Chongqing 400715, China.
- Chongqing Key Laboratory of Herbivore Science, Chongqing 400715, China.
ORCID-Profile: Yunyi Hu
Förderung
- National Natural Science Foundation of China
- Chongqing Graduate Student Research Innovation Project
- Science and technology research project of Chongqing Municipal Education Commission
- Chongqing Modern Agricultural Industry Technology System
- China Postdoctoral Science Foundation
- Collection, Utilization and Innovation of Germplasm Resources by Research Institutes and Enterprises of Chongqing, China
- Chongqing Science and Technology Innovation Special Project
Zitieren
APA
Zhu, Q., Hu, Y., Li, M., Yang, H., Zhao, L., & Zhao, Y. (2026). N6-Methyladenosine (m6A)-Mediated Regulation of Lipid Metabolism: Molecular Mechanisms, Pathological Implications, and Therapeutic Perspectives. Biomolecules. https://doi.org/10.3390/biom16010101
Vancouver
Zhu Q, Hu Y, Li M, Yang H, Zhao L, Zhao Y. N6-Methyladenosine (m6A)-Mediated Regulation of Lipid Metabolism: Molecular Mechanisms, Pathological Implications, and Therapeutic Perspectives. Biomolecules. 2026. doi:10.3390/biom16010101
BibTeX
@article{Zhu2026,
author = {Zhu, Qingjun and Hu, Yunyi and Li, Minhao and Yang, Haili and Zhao, Le and Zhao, Yongju},
title = {N6-Methyladenosine (m6A)-Mediated Regulation of Lipid Metabolism: Molecular Mechanisms, Pathological Implications, and Therapeutic Perspectives},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16010101}
}
EUVIMED